MULTINUCLEAR NMR PROBES OF BIOLOGICAL SYSTEMS
生物系统的多核核磁共振探针
基本信息
- 批准号:3226142
- 负责人:
- 金额:$ 22.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1979
- 资助国家:美国
- 起止时间:1979-05-01 至 1991-04-30
- 项目状态:已结题
- 来源:
- 关键词:Escherichia coli affinity chromatography alkaline phosphatase aminoacid metabolism aminoacid transport carbonate dehydratase carbonic anhydrase inhibitors catechol methyltransferase cations chemical binding chemical structure function enzyme structure enzyme substrate complex intestines kidney ligands ligase lipopolysaccharides membrane model membrane permeability membrane structure metalloenzyme metals methionine nuclear magnetic resonance spectroscopy pharmacology
项目摘要
The overall objectives are to develop and apply state-of-the-art NMR
techniques to the determination of the solution structural properties of
complex biological macromolecules in order to elucidate their mechanism of
action. The specific biological systems that will be studied by these
methods are metallothioneins and a cyclosporin binding protein, termed
cyclophilin.
Metallothioneins (MTs): A variety of NMR methods will be used to fully
resolve both the structural and metal-ion binding properties of this
ubiquitous, metal-ion inducible, low molecular weight, cysteine-rich
metal-binding protein isolated from various species in its long
evolutionary history (fungus, yeast, invertebrate and mammalian). These
very properties assures the ultimate importance of this protein in the
cellular regulation of essential (Zn, Cu) and nonessential (Cd, Hg) metal
ions. As a result, every effort will be made in these studies to elucidate
those aspects of the structure of these different MTs which alter its
metal-ion binding properties and to correlate this data with the presumed,
but as yet undefined, function of this family of proteins.
Cyclophilin is a ubiquitous, low molecular weight (17 Kd) cytosolic protein
with high specificity for binding cyclosporin A, a potent immunosuppressant
used clinically for the prevention of kidney, liver and heart allograft
rejection. The specific objectives will be to use one and two-dimensional
1H NMR methods to elucidate the solution structural properties of
cyclophilin, particularly as they relate to the binding site for
cyclosporin. Studies such as these are of utmost importance to
understanding the role of this protein in the pharmacologic activity of
cyclosporin and its active metabolites, and the structure-activity
relationships for cyclosporin. The long-term objectives would be to use
NMR, in conjunction with other biochemical methods, to characterize the
complex of cyclophilin with its intrinsic natural ligand when the latter is
isolated. These studies would provide important new insight into the
molecular mechanism of action of cyclosporin and the potential
physiological significance of cyclophilin in the regulation of cellular
metabolism.
总体目标是开发和应用最先进的核磁共振技术
的溶液结构性质的测定技术
复杂的生物大分子,以阐明其机制,
行动上 这些研究所要研究的特定生物系统
方法是金属硫蛋白和环孢菌素结合蛋白,称为
亲环素
金属硫蛋白(MT):将使用各种NMR方法来充分
解决这两个结构和金属离子结合性能,
普遍存在的、金属离子诱导的、低分子量的、富含半胱氨酸的
金属结合蛋白从各种物种中分离出来,
进化史(真菌、酵母、无脊椎动物和哺乳动物)。 这些
这些特性保证了这种蛋白质在生物学中的最终重要性。
细胞对必需金属(锌、铜)和非必需金属(镉、汞)的调节
离子。 因此,在这些研究中将尽一切努力阐明
这些不同MT的结构的那些方面改变了其
金属离子结合性质并将该数据与假定的,
但尚未明确的功能。
亲环素是一种普遍存在的低分子量(17 Kd)胞浆蛋白
具有高特异性结合环孢菌素A,一种有效的免疫抑制剂
临床上用于预防肾、肝和心脏移植
排斥反应 具体目标将是使用一维和二维
1H NMR方法来阐明溶液的结构特性
亲环素,特别是当它们涉及亲环素的结合位点时,
环孢菌素 像这样的研究对于
了解这种蛋白质在药物活性中的作用,
环孢菌素及其活性代谢物,以及结构-活性
环孢菌素的关系。 长期目标是利用
核磁共振,结合其他生物化学方法,以表征
亲环素与其内在天然配体的复合物,当后者是
与世隔绝 这些研究将提供重要的新见解,
环孢菌素作用的分子机制及其潜在的
亲环素在细胞凋亡调控中的生理意义
新陈代谢.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IAN M ARMITAGE其他文献
IAN M ARMITAGE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IAN M ARMITAGE', 18)}}的其他基金
HIGH FIELD NMR SPECTROMETER FOR BIOLOGICAL STUDIES
用于生物学研究的高场核磁共振波谱仪
- 批准号:
3519797 - 财政年份:1987
- 资助金额:
$ 22.55万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 22.55万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 22.55万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 22.55万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 22.55万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 22.55万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 22.55万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 22.55万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 22.55万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 22.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 22.55万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




